Suresh Pallikkuth Selected Research

HIV Infections (HIV Infection)

10/2021	IL-21 enhances influenza vaccine responses in aged macaques with suppressed SIV infection.
10/2021	Immunological age prediction in HIV-infected, ART-treated individuals.
1/2021	The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
1/2020	Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy.
1/2020	Impact of Early Antiretroviral Therapy Initiation on HIV-Specific CD4 and CD8 T Cell Function in Perinatally Infected Children.
12/2019	Pretransplant Levels of C-Reactive Protein, Soluble TNF Receptor-1, and CD38+HLADR+ CD8 T Cells Predict Risk of Allograft Rejection in HIV+ Kidney Transplant Recipients.
11/2019	Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy.
1/2019	Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study.
1/2019	Brief Report: Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users With Treated HIV Infection.
1/2018	Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suresh Pallikkuth Research Topics

Disease

27	HIV Infections (HIV Infection) 10/2021 - 12/2009
13	Inflammation (Inflammations) 01/2022 - 01/2013
9	Infections 06/2022 - 01/2013
9	Human Influenza (Influenza) 10/2021 - 08/2012
3	Virus Diseases (Viral Diseases) 11/2019 - 08/2012
3	Substance-Related Disorders (Drug Abuse) 01/2019 - 01/2018
2	Reinfection 06/2022 - 01/2022
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 12/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
2	COVID-19 01/2021 - 11/2020
2	Malaria 01/2021 - 01/2020
1	Hypoxia (Hypoxemia) 06/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Obesity 01/2022
1	Parasitemia 01/2021
1	Latent Infection 01/2020
1	Neoplasms (Cancer) 11/2019
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017
1	Persistent Infection 01/2013

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 10/2021 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
8	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2021 - 08/2012
8	interleukin-21 (interleukin 21)IBA 10/2021 - 11/2011
8	AntigensIBA 10/2021 - 01/2017
5	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2020 - 01/2018
3	CytokinesIBA 01/2022 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
3	Lipopolysaccharide ReceptorsIBA 12/2019 - 01/2013
2	HLA-DR Antigens (HLA-DR)IBA 01/2022 - 10/2017
2	Cocaine (Cocaine HCl)IBA 01/2022 - 01/2018
2	AIDS VaccinesIBA 01/2020 - 11/2011
2	LipopolysaccharidesIBA 12/2019 - 01/2018
2	Biological ProductsIBA 10/2017 - 01/2017
1	Messenger RNA (mRNA)IBA 06/2022
1	Peptides (Polypeptides)IBA 06/2022
1	Immunoglobulin G (IgG)IBA 06/2022
1	COVID-19 VaccinesIBA 01/2022
1	CholesterolIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	baricitinibIBA 01/2021
1	SolutionsIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	ruxolitinibIBA 01/2021
1	NeopterinIBA 01/2021
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2021
1	diformyl dapsone (DFD)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Malaria VaccinesIBA 01/2020
1	ImmunosorbentsIBA 12/2019
1	C-Reactive ProteinIBA 12/2019
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2019
1	EnzymesIBA 12/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2019
1	IntegrinsIBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Fatty Acid-Binding ProteinsIBA 01/2018
1	Vaccine AdjuvantsIBA 12/2013
1	Raltegravir Potassium FDA Link 11/2013
1	Viral Envelope ProteinsIBA 05/2013
1	Integrase InhibitorsIBA 05/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Interleukin-21 ReceptorsIBA 01/2012
1	Glutathione (Reduced Glutathione)IBA 12/2009
1	Proteins (Proteins, Gene)FDA Link 12/2009

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2009
5	Art Therapy 10/2021 - 01/2019
3	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 11/2013
1	Transplantation 06/2022
1	Immunotherapy 01/2018